CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Revenue

In the year 2024, CASI Pharmaceuticals had annual revenue of $28.54M, down -15.77%. CASI Pharmaceuticals had revenue of $13.36M in the quarter ending December 31, 2024, with 94.30% growth.

• Revenue (ttm): $28.54M
• Revenue Growth: -15.77%
• P/S Ratio: 1.08
• Revenue / Employee: $122,476
• Employees: 233
• Market Cap: 31.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.54M	-5.34M	-15.77%
Dec 31, 2023	33.88M	-9.23M	-21.41%
Dec 31, 2022	43.11M	12.94M	42.89%
Dec 31, 2021	30.17M	15.03M	99.25%
Dec 31, 2020	15.14M	11.01M	266.52%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.